Catalyst Wire Dossier Catalyst Wire Dossier

HLD200

· Ironshore Pharmaceuticals and Development, Inc.
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for HLD200, covering 2018-10-03 to 2025-11-06. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy, Safety & Pharmacokinetic (PK) Study of HLD200 in Children Aged 4-5 Years With ADHD [Phase 3]

See pricing